New Study Highlights Enabling Factors for Biopharmaceutical Innovation in Middle-Income Countries

[at noodls] – Charles River Associates was commissioned by The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) to produce an independent study on biopharmaceutical innovation in middle-income … more

View todays social media effects on CRAI

View the latest stocks trending across Twitter. Click to view dashboard

See who CRA is hiring next, click here to view